Physician profile
Edward M Lang
NPI 1699798769
$7,254.90
in general payments reported to CMS, 2019-2025
15 companies · $2,017 in 2025
The $2,017 reported for 2025 was more than what 90% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $669 · 2020: $1,122 · 2021: $219 · 2022: $1,898 · 2023: $75.74 · 2024: $1,255 · 2025: $2,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,749 · Food and Beverage: $598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,749.07 |
| Food and Beverage | $598.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,879.12 | 2022-2025 | |
| Alon Medical Technology | $901.44 | 2022-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $832.29 | 2019-2020 | |
| Arthrex, INC. | $405.89 | 2019-2025 | |
| Stryker Corporation | $348.84 | 2019-2022 | |
| Zyla Life Sciences, INC. | $226.20 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $195.69 | 2020-2021 | |
| Assertio Therapeutics, INC. | $162.37 | 2019-2020 | |
| Horizon Therapeutics Plc | $135.40 | 2019-2021 | |
| Biopoly LLC | $75.74 | 2023 | |
| Pfizer INC. | $29.30 | 2019-2020 | |
| Melinta Therapeutics, LLC | $21.37 | 2019 | |
| Merck Sharp & Dohme LLC | $16.48 | 2019 | |
| Smith+Nephew, INC. | $12.58 | 2021 | |
| Alfasigma USA, INC. | $12.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.